Breast cancer drug Supinoxin shows potential for small-cell lung cancer in new tests
Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung cancer (SCLC).
DNA origami offers more accurate imaging in the fight against pancreatic cancer
One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue
Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients
Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment.
Reprogramming cancer cells to treat an aggressive type of leukemia
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.
Common antiparasitic drug shows promise in halting growth of aggressive skin cancer
A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, according to research led by University of Arizona Cancer Center researchers
Detecting invasive nodules could be key to preventing unnecessary pancreatic cancer surgery
Pancreatic cysts are fluid-filled sacs that can form in the pancreas.
AI diagnoses endometrial cancer with near perfect accuracy
One of Australia’s most common gynecological cancers could be detected sooner and more accurately thanks to a specialized artificial intelligence (AI) model, new research shows.
How to prime tumors to be defeated by cancer immunotherapy
Experts have thought that immune cells had to be inside of tumors for one type of immunotherapy, known as checkpoint inhibitors, to work.
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug.
A new drug delivery system may help patients with a rare eye cancer
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver.
Scientists identify key protein driving ovarian cancer spread
A new study has identified the protein ADAMTS5 as playing a crucial role in the spread of ovarian cancer cells, offering a potential new target for future treatments.
Study suggests exercise could reduce breast cancer recurrence
Exercise could potentially reduce the recurrence rate of breast cancer, new research from Edith Cowan University (ECU) has found.
